Page 2 - ANTIFUNGAL SUSCEPTIBILITY OF CLINICAL YEAST ISOLATES 2018-2020

CONTENTS

List of contributing hospitals ............................................................................. 4

Fungal isolates acronyms and abbreviations .................................................... 5

Executive summary ............................................................................................. 6

Distribution of yeasts in 2018, 2019 and 2020 ................................................. 8

Candida albicans.............................................................................................. 10

Candida parapsilosis complex ......................................................................... 13

Candida tropicalis ….. ..................................................................................... 15

Candida glabrata complex ............................................................................... 18

Candida auris ................................................................................................... 21

Candida dubliniensis. ...................................................................................... 22

Cryptococcus neoformans complex ................................................................... 24

Trichosporon asahii ......................................................................................... 25

Kodamaea ohmeri (previously Pichia ohmeri)………………..………...…….…26

Pichia kudriavzevii (previously Candida krusei)…………………...…………..27

Clavispora lusitaniae (previously Candida lusitaniae) ……………………….28

Meyerozyma guilliermondii (previously Candida guilliermondii)…………...29

Candida haemulonii………………………………………………………………...30

Rhodotorula mucilaginosa……………………………………………….…………31

Acknowledgement and disclaimer…………………………………………………32

Future improvements…………………….……………...…………………………. 33

2 |